Scientists test new drug to Fine-Tune blood clotting treatments
NCT ID NCT06517563
Summary
This is an early-stage study to understand how a new drug, VMX-C001, affects the way common blood thinners work in the body. It involves 16 healthy volunteers who will receive the new drug alongside standard blood thinners like heparin and rivaroxaban. The main goal is to measure changes in various blood clotting tests to see if VMX-C001 safely alters the effects of these medications.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for COAGULATION DISORDER are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Locations
-
ICON
Groningen, 9728 NZ, Netherlands
Conditions
Explore the condition pages connected to this study.